Molecular basis of sperm-egg interaction and the prospects for immunocontraception.
As the molecular basis of sperm-egg interaction is resolved, so new opportunities are created for the development of immunological approaches to disrupt the process of conception. Thus, realisation that the zona glycoprotein, ZP3, serves as a specific receptor for spermatozoa, has prompted a detailed examination of its contraceptive potential. In primate models, recombinant ZP3 has been shown to suppress fertility very efficiently, however this efficacy is tempered by the appearance of adverse side-effects involving accelerated primordial follicle depletion and a lymphocytic infiltration of the ovarian stroma. Synthetic peptides encoding B-cell epitopes have been found to circumvent the lymphocyte response although the effectiveness of such reagents in preventing the loss of primordial follicles has not yet been determined. The induction of active immunity against sperm-specific antigens has also been shown to generate long term infertility in both males and females. Molecular and immunological techniques are now being used to produce a rapidly expanding list of unique sperm antigens which are currently being evaluated to determine their potential contribution to the development of safe, effective, contraceptive vaccines.
Kerr
L E
LE
MRC Reproductive Biology Unit, Centre for Reproductive Biology, Edinburgh, UK.
Paterson
M
M
Aitken
R J
RJ
D000818:Animals; D003267:Contraception; D005260:Female; D006801:Humans; D008297:Male; D013084:Sperm-Ovum Interactions / Q000276:immunology*; D015044:Zona Pellucida